Bacher, et al,, et al v. Boehringer Ingelheim Pharmaceuticals, Inc., et al,, et al
| Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. |
| Beth Bacher, Representative for Paul Bacher (Deceased) |
| 23-139 |
| January 27, 2023 |
| U.S. Court of Appeals, Second Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 27, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 3 DOCKET SHEET, RECEIVED.[3463483] [23-139] [Entered: 02/03/2023 10:27 AM] |
| Filing 2 DISTRICT COURT ORDER, dated 01/17/2023, RECEIVED.[3463480] [23-139] [Entered: 02/03/2023 10:26 AM] |
| Filing 1 MOTION, for leave to appeal, on behalf of Petitioner Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 01/27/2023 by US mail.[3463468] [23-139] [Entered: 02/03/2023 10:24 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
